Lomustine and bevacizumab in progressive glioblastoma

The addition of bevacizumab to lomustine in patients with recurrent glioblastoma failed to increase overall survival but was associated with a small increase in progression-free survival.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wick, Wolfgang (VerfasserIn) , Bendszus, Martin (VerfasserIn) , Sahm, Felix (VerfasserIn) , Harting, Inga (VerfasserIn) , Deimling, Andreas von (VerfasserIn) , Platten, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 16, 2017
In: The New England journal of medicine
Year: 2017, Jahrgang: 377, Heft: 20, Pages: 1954-1963
ISSN:1533-4406
DOI:10.1056/NEJMoa1707358
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1056/NEJMoa1707358
Verlag, Volltext: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1707358
Volltext
Verfasserangaben:Wolfgang Wick, Thierry Gorlia, Martin Bendszus, Martin Taphoorn, Felix Sahm, Inga Harting, Alba A. Brandes, Walter Taal, Julien Domont, Ahmed Idbaih, Mario Campone, Paul M. Clement, Roger Stupp, Michel Fabbro, Emilie Le Rhun, Francois Dubois, Michael Weller, Andreas von Deimling, Vassilis Golfinopoulos, Jacoline C. Bromberg, Michael Platten, Martin Klein, Martin J. van den Bent

MARC

LEADER 00000caa a2200000 c 4500
001 1565973194
003 DE-627
005 20230426064407.0
007 cr uuu---uuuuu
008 171204s2017 xx |||||o 00| ||eng c
024 7 |a 10.1056/NEJMoa1707358  |2 doi 
035 |a (DE-627)1565973194 
035 |a (DE-576)49597319X 
035 |a (DE-599)BSZ49597319X 
035 |a (OCoLC)1340983017 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
245 1 0 |a Lomustine and bevacizumab in progressive glioblastoma  |c Wolfgang Wick, Thierry Gorlia, Martin Bendszus, Martin Taphoorn, Felix Sahm, Inga Harting, Alba A. Brandes, Walter Taal, Julien Domont, Ahmed Idbaih, Mario Campone, Paul M. Clement, Roger Stupp, Michel Fabbro, Emilie Le Rhun, Francois Dubois, Michael Weller, Andreas von Deimling, Vassilis Golfinopoulos, Jacoline C. Bromberg, Michael Platten, Martin Klein, Martin J. van den Bent 
264 1 |c November 16, 2017 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.12.2017 
520 |a The addition of bevacizumab to lomustine in patients with recurrent glioblastoma failed to increase overall survival but was associated with a small increase in progression-free survival. 
700 1 |a Bendszus, Martin  |e VerfasserIn  |0 (DE-588)1032676426  |0 (DE-627)738634131  |0 (DE-576)175567697  |4 aut 
700 1 |a Sahm, Felix  |d 1984-  |e VerfasserIn  |0 (DE-588)1022852132  |0 (DE-627)717318478  |0 (DE-576)366075020  |4 aut 
700 1 |a Harting, Inga  |d 1971-  |e VerfasserIn  |0 (DE-588)12071342X  |0 (DE-627)704941872  |0 (DE-576)292352840  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Platten, Michael  |d 1971-  |e VerfasserIn  |0 (DE-588)121627780  |0 (DE-627)081431848  |0 (DE-576)261969811  |4 aut 
773 0 8 |i Enthalten in  |t The New England journal of medicine  |d Waltham, Mass. : MMS, 1928  |g 377(2017), 20, Seite 1954-1963  |h Online-Ressource  |w (DE-627)266889484  |w (DE-600)1468837-2  |w (DE-576)075962454  |x 1533-4406  |7 nnas  |a Lomustine and bevacizumab in progressive glioblastoma 
773 1 8 |g volume:377  |g year:2017  |g number:20  |g pages:1954-1963  |g extent:10  |a Lomustine and bevacizumab in progressive glioblastoma 
856 4 0 |u http://dx.doi.org/10.1056/NEJMoa1707358  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1056/NEJMoa1707358  |x Verlag  |3 Volltext 
856 4 0 |u http://www.nejm.org/doi/pdf/10.1056/NEJMoa1707358  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20171204 
993 |a Article 
994 |a 2017 
998 |g 121627780  |a Platten, Michael  |m 121627780:Platten, Michael  |d 60000  |d 62700  |e 60000PP121627780  |e 62700PP121627780  |k 0/60000/  |k 1/60000/62700/  |p 21 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 18 
998 |g 12071342X  |a Harting, Inga  |m 12071342X:Harting, Inga  |d 910000  |d 911100  |e 910000PH12071342X  |e 911100PH12071342X  |k 0/910000/  |k 1/910000/911100/  |p 6 
998 |g 1022852132  |a Sahm, Felix  |m 1022852132:Sahm, Felix  |d 910000  |d 912000  |e 910000PS1022852132  |e 912000PS1022852132  |k 0/910000/  |k 1/910000/912000/  |p 5 
998 |g 1032676426  |a Bendszus, Martin  |m 1032676426:Bendszus, Martin  |d 910000  |d 911100  |e 910000PB1032676426  |e 911100PB1032676426  |k 0/910000/  |k 1/910000/911100/  |p 3 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 910000  |d 911100  |e 910000PW120297736  |e 911100PW120297736  |k 0/910000/  |k 1/910000/911100/  |p 1  |x j 
999 |a KXP-PPN1565973194  |e 2988994188 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"note":["Gesehen am 04.08.25"],"name":{"displayForm":["Massachusetts Medical Society"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"New England journal of medicine","subtitle":"NEJM","title":"The New England journal of medicine"}],"language":["eng"],"origin":[{"dateIssuedDisp":"1928-","dateIssuedKey":"1928","publisherPlace":"Waltham, Mass. ; Boston, Mass.","publisher":"MMS ; MMS"}],"id":{"eki":["266889484"],"zdb":["1468837-2"],"issn":["1533-4406"]},"pubHistory":["198.1928 -"],"corporate":[{"role":"isb","display":"Massachusetts Medical Society"}],"disp":"Lomustine and bevacizumab in progressive glioblastomaThe New England journal of medicine","part":{"volume":"377","pages":"1954-1963","text":"377(2017), 20, Seite 1954-1963","year":"2017","extent":"10","issue":"20"},"recId":"266889484","titleAlt":[{"title":"NEJM"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"person":[{"role":"aut","display":"Wick, Wolfgang","family":"Wick","given":"Wolfgang"},{"given":"Martin","role":"aut","family":"Bendszus","display":"Bendszus, Martin"},{"family":"Sahm","display":"Sahm, Felix","role":"aut","given":"Felix"},{"family":"Harting","display":"Harting, Inga","role":"aut","given":"Inga"},{"family":"Deimling","display":"Deimling, Andreas von","role":"aut","given":"Andreas von"},{"given":"Michael","role":"aut","display":"Platten, Michael","family":"Platten"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"November 16, 2017","dateIssuedKey":"2017"}],"recId":"1565973194","id":{"eki":["1565973194"],"doi":["10.1056/NEJMoa1707358"]},"note":["Gesehen am 04.12.2017"],"name":{"displayForm":["Wolfgang Wick, Thierry Gorlia, Martin Bendszus, Martin Taphoorn, Felix Sahm, Inga Harting, Alba A. Brandes, Walter Taal, Julien Domont, Ahmed Idbaih, Mario Campone, Paul M. Clement, Roger Stupp, Michel Fabbro, Emilie Le Rhun, Francois Dubois, Michael Weller, Andreas von Deimling, Vassilis Golfinopoulos, Jacoline C. Bromberg, Michael Platten, Martin Klein, Martin J. van den Bent"]},"physDesc":[{"extent":"10 S."}],"title":[{"title_sort":"Lomustine and bevacizumab in progressive glioblastoma","title":"Lomustine and bevacizumab in progressive glioblastoma"}],"language":["eng"]} 
SRT |a WICKWOLFGALOMUSTINEA1620